CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-08 | SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT | Grant or award · Option (Right to Buy) | +140,000 | 140,000 | ||
| 2022-11-17 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +46,154 | 145,285 | ||
| 2022-11-17 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +46,154 | 126,753 | ||
| 2022-11-17 | Parks Diane L. Director | Grant or award · Stock Option (Right to Buy) | +46,154 | 112,504 | ||
| 2022-11-17 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +46,154 | 129,747 | ||
| 2022-05-18 | Straube Richard SENIOR VICE PRESIDENT AND CMO | Purchase | +8,000 | $0.50 | $4K | 8,000 |
| 2022-05-18 | SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT | Purchase | +20,000 | $0.44 | $9K | 90,095 |
| 2022-01-21 | Guarino Jonathan L. CHIEF FINANCIAL OFFICER | Grant or award · Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-01-21 | SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT | Grant or award · Option (Right to Buy) | +47,315 | 47,315 | ||
| 2022-01-03 | SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT | Grant or award · Option (Right to Buy) | +60,000 | 60,000 | ||
| 2021-12-17 | SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT | Purchase | +7,000 | $0.74 | $5K | 70,095 |
| 2021-12-15 | Guarino Jonathan L. Senior Vice President and CFO | Purchase | +1,000 | $0.70 | $700 | 11,000 |
| 2021-12-14 | Guarino Jonathan L. Senior Vice President and CFO | Purchase | +10,000 | $0.71 | $7K | 10,000 |
| 2021-12-14 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +10,000 | $0.73 | $7K | 63,095 |
| 2021-12-09 | SCHABER CHRISTOPHER J Chairman, CEO and President | Grant or award · Option (Right to Buy) | +60,000 | 60,000 | ||
| 2021-12-09 | Donini Oreola CSO | Grant or award · Option (Right to Buy) | +70,000 | 70,000 | ||
| 2021-12-09 | Guarino Jonathan L. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-12-09 | Straube Richard CMO | Grant or award · Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-09-23 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +29,126 | 29,126 | ||
| 2021-09-23 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +29,126 | 29,126 |
Page 5 of 8 · 141 trades